Open an account

Bon Natural Life

BON · NASDAQ

$1.16+$0.0061 (+0.53%)TodayMarket closed ·
Prev close $1.15

About BON

Bon Natural Life Ltd. engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants which are widely used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company is headquartered in Xi'An, Shaanxi and currently employs 96 full-time employees. The company went IPO on 2021-06-24. The firm's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

Employees
96
Headquarters
Xi'an, Shaanxi
Listed
Jun 24, 2021
Sector
Materials
Industry
Chemicals
Website
bnlus.com

BON key statistics

Market cap
9.43M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
11.59K
Volume
10.87K
Open price
$1.12
High today
$1.16
Low today
$1.12
52 Week high
$2.07
52 Week low
$0.95

Bon Natural Life (BON) at a glance

Bon Natural Life (BON) last traded at $1.16, with a market cap of 9.43M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $1.12 and $1.16. The current price is 3.1% above the day's low and 0.4% below its high.

Volume so far is 10.87K shares, in line with the average of 11.59K shares a day.

Over the past year Bon Natural Life has ranged from $0.95 to $2.07, and now sits 18% of the way up that range.

BON news

  • 11 Materials Stocks Moving In Wednesday's After-Market Session

  • Press releasePRNewswire

    BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives

  • Press releasePRNewswire

    BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market

  • Press releasePRNewswire

    BON Partners with Chang'an Pilot to Launch World-Class Joint Laboratory for Natural Ingredient Bio-manufacturing

  • Press releasePRNewswire

    BON Unveils Kombucha-Inspired Product, Inks $12 Million Strategic Sales Agreement with Qingshengyuan

  • Press releasePRNewswire

    BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan

  • Press releasePRNewswire

    BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products

  • Press releasePRNewswire

    BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.